Study: Statins don't cause cancer

We know statins lower LDL, or "bad" cholesterol. We also know that they tend to lower HDL, or "good" cholesterol, too. And we suspect that it's possible for low LDL levels to boost the risk of cancer. So, do statins increase the risk of cancer? Well, no, according to a new metanalysis published in the Journal of the American College of Cardiology.

The study found that yes, statins lowered LDL and that patients with lower LDL did have a greater risk of cancer. But, their statistics showed, the statins weren't the culprit in that cancer risk. You see, the people in the studies who didn't take statins also had a higher risk of cancer if their LDL was lower. And that risk in both lower-LDL groups was roughly the same.

Still, cardiology experts said that the FDA and drugmakers should analyze their statin trial data for cancer incidence, because the possible link between very low LDL and cancer is worrisome--and therefore it might not be safe to use statins to push cholesterol to super-low levels. That could trade lower cardio risk for higher cancer risk.

--read the item at Pharmalot
--see the study in JACC
--check out an analysis from Heartwire

Suggested Articles

The Trump administration has selected five COVID-19 vaccines for Operation Warp Speed, the NYT reports, with Big Pharma dominating the list.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

Bristol Myers Squibb's Zeposia will leverage promising top-line phase 3 data into a possible FDA approval in the lucrative ulcerative colitis market.